Articles

• CHIEF MEDICAL EDITOR’S PAGE: The Long Wait for New Treatment Options

  By Robert L. Avery, MD and Allen C. Ho, MD

NEWS

• Radiation Therapy for Age-Related Macular Degeneration

  Two investigational devices are designed to provide targeted delivery of radiation to reduce damage to the optic nerve and surrounding tissues.

  By Compiled BY Jennifer Kreatsoulas, PHD, Senior Associate Editor

• Intensive Training Program Offers European Surgeons Unique Learning Opportunity

  The European VitreoRetinal Training School (EVRTS) brings newer surgeons together with the experts in retina.

  By Rachel M. Renshaw, Editor-In-Chief

BUSINESS OF RETINA

• The Retina Specialist’s Field Guide to Site Selection

  By Avner Ingerman, MD, MSC; Ashley Lafond; and David Waters-Honcu

• FELLOWS’ FOCUS: Finding Professional and Personal Balance as a Fellow: Part 2

  By Eugene A. Milder, MD; Paul S. Baker, MD; and Allen Chiang, MD; with Jason HSU, MD; and Carl Park, MD

• RETINA IN THE ASC: Challenges of Being a Well-rounded Retina Specialist

  With the right strategy, one can happily manage multiple commitments.

  By J. Fernando Arevalo, MD, FACS

RETINA SURGERY

• GLOBAL PERSPECTIVES: Advanced Training in Retinal Diseases

  The European School for Advanced Studies in Ophthalmology offers young physicians an interdisciplinary and international postgraduate training experience.

  By Stanislao Rizzo, MD; and Giuseppe Guarnaccia, MD

• RETINA PEARLS: Fundus Visualization With Wide-angle Viewing Systems

  These devices allow surgeons to recognize fundus pathology and treat lesions safely and effectively.

  By Masahito Ohji, MD

• SURGICAL UPDATES: Pearls for Persistent Fetal Vasculature Cases

  By With Audina M. Berrocal, MD

RETINAL ONCOLOGY

• CASE REPORTS IN OCULAR ONCOLOGY: Small Choroidal Melanoma With All Eight Risk Factors for Growth

  By Felina V. Zolotarev, BA; Kiran Turka, MD; and Carol L. Shields, MD

COVER STORIES

• Complement Factor 5 Inhibition in Age-related Macular Degeneration

  ARC1905 shows promise for enhanced efficacy in eyes with wet AMD.

  By Jordi Monés, MD

• Fenretinide Treatment of Geographic Atrophy in Dry AMD: Preliminary Results

  By Alexander M. Eaton, MD

• Preliminary Results With Noninvasive Radiation Therapy for Wet AMD

  By Peter K. Kaiser, MD; and Viriglio Morales-Canton, MD

• Dexamethasone Implant for Treatment of DME in Vitrectomized Patients

  A prospective, 6-month, open-label study shows promising results.

  By Leonard Feiner, MD

• CNTF-secreting Implant for Geographic Atrophy

  Eighteen-month results show device to be well-tolerated with no serious adverse events.

  By Glenn J. Jaffe, MD

• Reducing the Treatment Burden for AMD

  Combination therapy with anti-VEGF plus epimacular brachytherapy holds promise.

  By Pravin U. Dugel, MD

• Safety and Efficacy in a Phase 1 Trial for Epimacular Brachytherapy

  By David S. Boyer, MD

• Fluocinolone Insert’s Impact on Overall Risk of Procedures

  In an analysis of FAME study data, risk of subsequent procedures was reduced in treated patients.

  By P. Andrew Pearson, MD

• Human Visual Cycle Modulation for Dry AMD

  Novel oral nonretinoid treatment targets visual cycle process that creates toxic byproducts implicated in retinal diseases.

  By Nancy Boman, MD, PHD

RETINA SURGERY

• Panretinal Photocoagulation in Patients with DME

  Laser remains the mainstay of treatment in DME.

  By Pascale Massin, MD

DEPARTMENTS

• INNOVATIONS

  A preview of today’s new products

• 5 Questions with Susanne Binder, MD

  Dr. Binder is Professor and Chairman of the Department of Ophthalmology of the Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery, Rudolf Foundation Clinic, in Vienna, Austria.

View All News >